Capecitabine plus oxaliplatin for the first-line treatment of elderly patients with metastatic colorectal carcinoma: final results of the Southern Italy Cooperative Oncology Group Trial 0108. (Q46538590)

From Wikidata

Jump to navigation Jump to search

scientific article published in July 2005

Language	Label	Description	Also known as
English	Capecitabine plus oxaliplatin for the first-line treatment of elderly patients with metastatic colorectal carcinoma: final results of the Southern Italy Cooperative Oncology Group Trial 0108.	scientific article published in July 2005

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15948167%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Capecitabine plus oxaliplatin for the first-line treatment of elderly patients with metastatic colorectal carcinoma: final results of the Southern Italy Cooperative Oncology Group Trial 0108 (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15948167%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

0 references

1 reference

based on heuristic

inferred from title

metastatic colorectal carcinoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Antonio Gambardella

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15948167%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Pasquale Comella

1

object named as

Pasquale Comella

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15948167%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

6

object named as

Bruno Massidda

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15948167%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Rossana Casaretti

7

object named as

Rossana Casaretti

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15948167%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

5

object named as

Luigi Maiorino

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15948167%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

author name string

Donato Natale

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15948167%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Antonio Farris

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15948167%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Salvatore Tafuto

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15948167%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Vito Lorusso

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15948167%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Silvana Leo

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15948167%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Michele Cannone

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15948167%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

language of work or name

0 references

publication date

1 July 2005

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15948167%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15948167%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

104

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15948167%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15948167%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

282-289

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15948167%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Cancer statistics, 1999.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21167

7 January 2021

based on heuristic

inferred from DOI database lookup

Should chemotherapy be used as a treatment of advanced colorectal carcinoma (ACC) in patients over 70 years of age?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21167

7 January 2021

based on heuristic

inferred from DOI database lookup

Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21167

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21167

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21167

7 January 2021

based on heuristic

inferred from DOI database lookup

Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21167

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: results of a randomized phase III study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21167

7 January 2021

based on heuristic

inferred from DOI database lookup

Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21167

7 January 2021

based on heuristic

inferred from DOI database lookup

Capecitabine as first-line treatment in colorectal cancer. Pooled data from two large, phase III trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21167

7 January 2021

based on heuristic

inferred from DOI database lookup

Capecitabine (Xeloda) in combination with oxaliplatin: a phase I, dose-escalation study in patients with advanced or metastatic solid tumors.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21167

7 January 2021

based on heuristic

inferred from DOI database lookup

XELOX (capecitabine plus oxaliplatin): active first-line therapy for patients with metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21167

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacology of antineoplastic agents in older cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21167

7 January 2021

based on heuristic

inferred from DOI database lookup

A tailored regimen including capecitabine and oxaliplatin for treating elderly patients with metastatic colorectal carcinoma Southern Italy Cooperative Oncology Group trial 0108.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21167

7 January 2021

based on heuristic

inferred from DOI database lookup

“Mini-mental state”

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21167

7 January 2021

based on heuristic

inferred from DOI database lookup

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21167

7 January 2021

based on heuristic

inferred from DOI database lookup

Reporting results of cancer treatment

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21167

7 January 2021

based on heuristic

inferred from DOI database lookup

Optimal two-stage designs for phase II clinical trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21167

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21167

7 January 2021

based on heuristic

inferred from DOI database lookup

Differential prognostic impact of comorbidity

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21167

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized multicenter phase II trial of two different schedules of capecitabine plus oxaliplatin as first-line treatment in advanced colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21167

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II study of capecitabine and oxaliplatin in first- and second-line treatment of advanced or metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21167

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II study of capecitabine and oxaliplatin as first-line treatment in advanced colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21167

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46538590&oldid=1785321991"